Around 12,000 U.S. children will be used as guinea pigs for an experimental swine flu vaccine known to contain the dangerous ingredient squalene, which has been directly linked with cases of Gulf War Syndrome and a host of other debilitating diseases.
According to a report in the Oklahoman, 12,000 children nationwide will partake in "fast-tracked studies" to test the side-effects of the untested swine flu vaccine in trials set to begin next month.
"The trials will test the vaccine's effectiveness and whether or not it has negative side effects in patients," states the report.
According to Meryl Nass, M.D., "A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities."